Search

ABTL0812 has been given the International Non-proprietary Designation (INN) ibrilatazar on the recommended list of INNs issued by the World Health Organization (WHO).

The Madrid-based laboratory, together with Histocell and Cardiva, has launched Histokine, located in the Basque Country (Spain). It is the first GMP-certified plant approved by a regulator to

Mats brings over 37 years of experience in the pharmaceutical industry, with a career marked by significant contributions in Discovery, Development, Manufacturing, IT R&D, Patents, Clinical Science

Research and development (R&D) expenses of $4.9m for the half-year ending June 30, 2024. As a result of the completion of the PORTICO clinical trial, the company saves $3.7M compared to the half-year

The core idea of Open innovation is that companies leverage the ideas and resources of external actors such as customers, suppliers, universities, start-ups, etc.

The guidelines presented by the President of the European Commission, Ursula von der Leyen, highlight biotechnology and the revolution stemming from its innovations as fundamental to the future of the

Esta certificación significa que el sistema ACORYS MAPPING SYSTEM cumple con los altos estándares de seguridad, salud y protección ambiental requeridos para dispositivos médicos en la Unión Europea.

This funding will enable Integra Therapeutics to launch its first gene therapy to treat a serious pediatric hepatic disease, among other activities.

The episode will focus on oligonucleotide LC-MS, covering key challenges, the critical importance of assay sensitivity, and various analytical approaches and technologies that are currently used, have

"Currently, the outbreak of EHDV serotype 8 is generating great alarm due to its epidemic potential and the absence of a vaccine to date," explains Beatriz Díaz Lorenzo, Communications & Corporate

The "European Innovation Scoreboard 2024" highlights Spain's strengths in digitalization, educational level, and resource productivity, while business investment and the inclusion of innovative

We trust that the call will strengthen the country's clinical research capabilities, which will help consolidate Spain's position on an international scale. We positively value the inclusion of IVD

Meet Conoce a Watson Marlow, our new member. We spoke with Jaume Tarragó, Iberia General Director.

Within the framework of the Smartfarm project, AINIA has made significant strides in the efficient and sustainable production of cultivated meat, a sustainable alternative that could help meet the

In less than 3 years, the Spanish biotech company has attracted the confidence of investors and international medical institutions to complete the development of its Viva Sepscare® prototype for the

For the treatment of Borderline Personality Disorder (BPD) and Attention Deficit Hyperactivity disorder (ADHD).

The participation of two of the participating sites in Spain, Hospital Universitario de Toledo and Hospital Universitario Reina Sofía de Córdoba, has already started, and the Hospital General

The agenda also emphasizes the need to promote research and innovation, as well as public procurement tools, in the field of emerging and enabling technologies such as biotechnology.

PLG is diverse and growing, with many resources in different countries to expand our support to clients in new ways. Insourcing provides ample opportunities for improved working for both PLG and

The new Aporta platform is distinguished by offering a complete and personalized solution for flexible remuneration, allowing companies to adapt benefits to the individual needs of each employee.

The deadline for transitioning clinical trials to CTIS ends on January 30, 2025. Studies continuing beyond this date must comply with the Clinical Trials Regulation (CTR), replacing the old CTD. At